Although most Americans appear to favor price controls on medicines, a recent survey indicates there is also some hesitancy if such a move would limit innovation that produces new drugs. The findings suggest warnings issued by the pharmaceutical industry that price controls might impede the flow of needed salves have caught the attention of a growing swath of the public.
Specifically, about 63 percent of adults do not want the government to control prices if that yields fewer innovative drugs, according to the survey of 1,240 adults released by Wells Fargo analyst David Maris. He noted there was little difference expressed regardless of the sex, age, or region of the country. In fact, 55 percent or more of each age bracket worried that innovation would suffer.